Efficacy and safety of teneligliptin in Indian patients with inadequately controlled Type 2 diabetes mellitus: A randomized, double-blind study

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Double Blind ◽

Indian Patients

Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a multi-centre, randomized, placebo-controlled, double-blind study

Diabetes Obesity and Metabolism ◽

10.1111/dom.12745 ◽

2016 ◽

Vol 18 (12) ◽

pp. 1207-1216 ◽

Cited By ~ 29

Author(s):

Hisamitsu Ishihara ◽

Susumu Yamaguchi ◽

Ikko Nakao ◽

Akira Okitsu ◽

Seitaro Asahina

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Japanese Patients ◽

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Effects ofα-Lipoic Acid, Carnosine, and Thiamine Supplementation in Obese Patients with Type 2 Diabetes Mellitus: A Randomized, Double-Blind Study

Journal of Medicinal Food ◽

10.1089/jmf.2018.0007 ◽

2018 ◽

Vol 21 (12) ◽

pp. 1197-1203 ◽

Cited By ~ 12

Author(s):

Spyridon Karkabounas ◽

Nikolaos Papadopoulos ◽

Chryssa Anastasiadou ◽

Chrysoula Gubili ◽

Dimitrios Peschos ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Lipoic Acid ◽

Blind Study ◽

Double Blind Study ◽

Obese Patients ◽

Efficacy and safety of evogliptin versus sitagliptin as an add-on therapy in Indian patients with type 2 diabetes mellitus inadequately controlled with metformin: A 24-week randomized, double-blind, non-inferiority, EVOLUTION INDIA study

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2019.107860 ◽

2019 ◽

Vol 157 ◽

pp. 107860 ◽

Cited By ~ 2

Author(s):

Ajay Kumar Ajmani ◽

Aparna Agrawal ◽

B.L.N. Prasad ◽

Indraneel Basu ◽

Jayashree Shembalkar ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Efficacy And Safety ◽

Double Blind ◽

Indian Patients

Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a 36-week, open-label extension of a 16-week, randomized, placebo-controlled, double-blind study

Diabetology International ◽

10.1007/s13340-018-0359-x ◽

2018 ◽

Vol 10 (1) ◽

pp. 37-50 ◽

Cited By ~ 3

Author(s):

Hisamitsu Ishihara ◽

Susumu Yamaguchi ◽

Ikko Nakao ◽

Seitaro Asahina ◽

Taishi Sakatani

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Japanese Patients ◽

Double Blind Study ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

Open Label Extension

A Multicenter, Prospective, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared with Placebo in Type 2 Diabetes Mellitus Patients Having Hypertriglyceridemia Not Controlled with Atorvastatin Therapy (PRESS VI)

Diabetes Technology & Therapeutics ◽

10.1089/dia.2013.0253 ◽

2014 ◽

Vol 16 (2) ◽

pp. 63-71 ◽

Cited By ~ 49

Author(s):

Rajendrakumar H. Jani ◽

Vikas Pai ◽

Pramod Jha ◽

Gunjan Jariwala ◽

Satinath Mukhopadhyay ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

Safety And Efficacy ◽

Atorvastatin Therapy

A Phase 2, 12-Week, Double-Blind, Efficacy and Safety of GX-G6 in Patients With Uncontrolled Type 2 Diabetes Mellitus

Case Medical Research ◽

10.31525/ct1-nct03962010 ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Phase 2 ◽

Efficacy And Safety ◽

Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study

Diabetologia ◽

10.1007/s00125-021-05460-0 ◽

2021 ◽

Author(s):

Linong Ji ◽

Ying Du ◽

Min Xu ◽

Xiangjun Zhou ◽

Zhaohui Mo ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Phase Ii ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Treatment Naïve

Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone

Current Medical Research and Opinion ◽

10.1185/03007995.2014.909393 ◽

2014 ◽

Vol 30 (7) ◽

pp. 1257-1266 ◽

Cited By ~ 44

Author(s):

Anil Pareek ◽

Nitin Chandurkar ◽

Nihal Thomas ◽

Vijay Viswanathan ◽

Alaka Deshpande ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Efficacy And Safety ◽

Efficacy and Safety of Exenatide Once Weekly Versus Metformin, Pioglitazone, and Sitagliptin Used as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4): A 26-week double-blind study

Diabetes Care ◽

10.2337/dc11-1107 ◽

2011 ◽

Vol 35 (2) ◽

pp. 252-258 ◽

Cited By ~ 210

Author(s):

D. Russell-Jones ◽

R. M. Cuddihy ◽

M. Hanefeld ◽

A. Kumar ◽

J. G. Gonzalez ◽

...

Keyword(s):

Type 2 Diabetes ◽

Diabetes Duration ◽

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Double Blind ◽

Drug Naïve

Re: Pareek A, Chandurkar N, Thomas N, et al. Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone. Curr Med Res Opin 2014;30:1257-66

Current Medical Research and Opinion ◽

10.1185/03007995.2015.1035242 ◽

2015 ◽

Vol 31 (6) ◽

pp. 1087-1092

Author(s):

Anil Pareek

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Efficacy And Safety ◽